On July 2, 2025, the kick-off meeting for the informatization construction project of Amoytop Biotech Production Center was successfully held in Xiamen. Mr. Zhang, Deputy General Manager of Amoytop Biotech, Mr. Paul Dong, CEO of Wellthinic Technology, Mr. Evan An, Deputy General Manager of Wellthinic Technology, and the project team members from both sides, gathered at the venue to jointly witness this milestone moment of digital cooperation in the industry.

A Powerful Alliance: Building the Foundation for Cooperation with Professional Expertise

Amoytop Biotech is an innovative biopharmaceutical enterprise listed on Sci-Tech Innovation Board (STAR Market). With decades of dedication to the field of recombinant protein drugs, it has built a full-chain innovation system from basic research to industrialization. Boasting top-tier R&D platforms such as the National Enterprise Postdoctoral Research Station and the National Engineering Research Center, it stands as a benchmark representative of "National Innovative Enterprise" and "National Key High-Tech Enterprise".

Wellthinic Technology, a leader in digital solutions for the pharmaceutical and batch process industries, has a profound understanding of global pharmaceutical production regulatory standards. With over 20 years of industry experience, it has provided digital transformation services to 80% of the world's top 20 pharmaceutical companies. It has accumulated rich practical experience in fields such as production control, quality traceability, and regulatory validation, laying a solid foundation for this cooperation.

Empowerment through Digitalization and Intelligence: Reconstructing the Entire Value Chain of Biopharmaceutical Production

The core goal of this project is to build a "digital sharing and business collaboration platform". Wellthinic Technology will provide Amoytop Biotech with an integrated automation + digital solution with multiple core functions: By adopting the world-leading Siemens digital platform, it will realize the electronic production batch records, ensuring the full traceability of production data; at the same time, a lean management module will be integrated to help improve the quality of product production and operation, and build a full-link digital service system driven by data.

Mr. Zhang, Deputy General Manager of Amoytop Biotech, stated that this cooperation is of far-reaching significance. It has taken four to five years of preparation from project planning to the kick-off. Both parties should establish a regular communication mechanism, strictly control the project progress and quality through standardized processes, adhere to the timeline, ensure the project is delivered with high quality and high standards, and work together to build an industry benchmark.

Mr. Paul Dong, CEO of Wellthinic Technology, pointed out that the biopharmaceutical industry has extremely high requirements for the accuracy, compliance and integrity of digitalization. Leveraging years of practical experience in the pharmaceutical industry, Wellthinic Technology will help enterprises realize the in-depth integration of "digital production lines" and "physical production lines", and jointly support Amoytop Biotech in expanding into overseas markets and moving towards global high-end pharmaceutical manufacturing.

Creating the Future with Intelligence: Establishing a New Paradigm for the Industry

With the successful conclusion of the kick-off meeting, this cooperation will not only inject new digital and intelligent momentum into the enterprise, but also provide replicable and promotable transformation experience for the biopharmaceutical industry. With data as the sail and wisdom as the oar, Wellthinic Technology will jointly draw a new picture of digitalization and intelligence in the pharmaceutical industry, and wish the project a complete success!